Senior insider sale
Sr. V.P., Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$142.7K
5K shares
What this filing means
MARTIN TAMI TILLOTSON plans to sell 5K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $142.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/16/2024ACC: 0001963745-24-000043
Officer· Sr. V.P., Regulatory Affairs
Since Feb 2020
5K
Shares to sell
$142.7K
Approx. market value
5K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
6/25/2024
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2024 | Exercise of options under a registered plan Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5K
Market value
$142.7K
6/25/2024
Total
Units
5K
Value
$142.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/25/2024 | 5K | $142.7K | NASDAQ | Planned |
| Total | 5K | $142.7K | ||